68Ga-DOTA-hLAG-3

N/A

Report date: 2025/10/20 14:27:27

NME

Base Information

Drug Name68Ga-DOTA-hLAG-3

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionLymphocyte activation gene 3 protein binders

TargetsLymphocyte activation gene 3 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesThe First Affiliated Hospital Of Xiamen University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Xiamen University

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A